Therapeutic application of a thienycyclohexylamine derivative
AssigneeSociete de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
InventorsGuy Lallement, Pierre D'Arbigny, Jean-Marc Kamenka
Life of this patent
Estimating the term…
Abstract
A method of inhibiting effects of neurotoxic products in warm-blooded animals comprising administering to warm-blooded animals an amount of 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in substantially pure racemic, diastereoisomeric or enantiomeric form effect to inhibit effects of neurotropic products and mixtures of thienyl cyclohexylamine and at least one member of the group consisting of anticholinergic, anticonvulsant or cholinesterase-reactivating substances.
Claims15
A method of inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals comprising administering to warm-blooded animals an amount of 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in substantially pure racemic, diastereoisomeric or enantiomeric form effective to inhibit effects of exogenous neurotropic or neurotoxinic products.
A composition for inhibiting exogenous neurotropic or neurotoxinic effects comprising an exogenous neurotoxic or neurotoxinic inhibitorily effect amount of 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in substantially pure racemic, diastereoisomeric or enantiomeric form and at least one other pharmaceutical capable of limiting said effects chosen from anticholinergic substances and substances which reactivate cholinesterases and an inert pharmaceutical carrier.
Dependencies are inferred from the claim text.